Home › Major Depressive Disorder › Nebraska
Major Depressive Disorder clinical trials in Nebraska
3 studies for Major Depressive Disorder are looking for participants at sites in Nebraska.
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Be Well Clinical Studies - Omaha, Omaha
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 1, 2026 · NCT07775300A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Omaha
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07105111ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Alivation Research, LLC, Lincoln
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 14, 2026 · NCT07284667From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.